CompanyBCAXNasdaqBoston, MA

Bicara Therapeutics

Bicara develops bifunctional therapies for solid tumors.

SEC EDGAR ClinicalTrials.gov bicara.com

424B5Oct 1Latest SEC filing

Sep 8Latest story

September 2026

Bicara Therapeutics updates registry record NCT07807163: recruiting

Sep 8Trial updateBicara Therapeutics ficerafusp alfaRecord notice

August 2026

Bicara Therapeutics finalizes Boston headquarters sublease with Wayfair LLC

Aug 25PartnershipBicara Therapeutics

Bicara names successor CEO, reports pivotal trial on track for 2027 readout

Aug 11Quarterly updateBicara Therapeutics

July 2026

Bicara Therapeutics names two new directors as Mazumdar-Shaw exits board

Jul 28PeopleBicara Therapeutics